Allstate (NYSE:ALL - Free Report) had its price target hoisted by Keefe, Bruyette & Woods from $235.00 to $240.00 in a research report report published on Tuesday morning,Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the insurance provider's stock.
Other equities research analysts also recently issued reports about the stock. BMO Capital Markets increased their price objective on shares of Allstate from $205.00 to $214.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Piper Sandler boosted their price objective on shares of Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a research report on Tuesday, November 26th. UBS Group raised their target price on Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a report on Monday, November 4th. The Goldman Sachs Group upped their price objective on Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a research report on Friday, November 15th. Finally, Wells Fargo & Company boosted their target price on Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a research note on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $217.94.
View Our Latest Stock Report on ALL
Allstate Stock Performance
NYSE ALL traded down $5.24 during trading on Tuesday, reaching $187.53. The company's stock had a trading volume of 3,917,486 shares, compared to its average volume of 1,603,816. Allstate has a 12 month low of $153.87 and a 12 month high of $209.88. The firm has a 50 day moving average price of $190.91 and a 200 day moving average price of $189.63. The firm has a market capitalization of $49.66 billion, a price-to-earnings ratio of 11.04, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, equities analysts anticipate that Allstate will post 18.64 EPS for the current fiscal year.
Insider Activity
In related news, CFO Jesse E. Merten sold 40,102 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.80% of the company's stock.
Institutional Investors Weigh In On Allstate
A number of institutional investors have recently modified their holdings of the company. VSM Wealth Advisory LLC bought a new stake in Allstate during the fourth quarter valued at $25,000. FSA Wealth Management LLC bought a new stake in shares of Allstate during the 3rd quarter valued at about $26,000. Twin Tree Management LP acquired a new stake in Allstate during the fourth quarter worth approximately $27,000. Northwest Investment Counselors LLC bought a new stake in Allstate in the third quarter worth approximately $28,000. Finally, Vision Financial Markets LLC acquired a new position in Allstate in the fourth quarter valued at approximately $29,000. 76.47% of the stock is owned by institutional investors.
About Allstate
(
Get Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
